Rational Design,Synthesis, Biophysical and Antiproliferative Evaluation of Fluorenone Derivatives with DNA G‐Quadruplex Binding Properties |
| |
Authors: | Stefano Alcaro Prof. Anna Artese Dr. James N. Iley Prof. Sotiris Missailidis Prof. Francesco Ortuso Dr. Lucia Parrotta Dr. Raffaele Pasceri Dr. Francesco Paduano Dr. Claudia Sissi Prof. Francesco Trapasso Dr. Maria Gabriella Vigorita Prof. |
| |
Affiliation: | 1. Dipartimento di Scienze Farmacobiologiche, Università degli Studi “Magna Gr?cia” di Catanzaro, Complesso Ninì Barbieri, 88021 Roccelletta di Borgia (CZ) (Italy), Fax: (+39)?0961‐391490;2. Department of Chemistry and Analytical Sciences, The Open University, Walton Hall, Milton Keynes, MK7?6AA (UK);3. Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi “Magna Gr?cia” di Catanzaro, Campus “S. Venuta”, viale Europa, 88100 Catanzaro (Italy);4. Dipartimento di Scienze Farmaceutiche, Università degli Studi di Padova, via Marzolo 5, 35131 Padova (Italy);5. Dipartimento Farmaco‐Chimico, Facoltà di Farmacia, Università degli Studi di Messina, Viale S.S. Annunziata, 98168 Messina (Italy) |
| |
Abstract: | Molecular modeling studies carried out with experimental DNA models with the sequence d[AG3(T2AG3)3] suggest that the introduction of a net positive charge onto the side chain of a series of fluorenone carboxamides can improve G‐quadruplex binding. The terminal morpholino moiety was replaced with a novel N‐methylmorpholinium cation starting from two 4‐carboxamide compounds. A different substitution on the fluorenone ring was also investigated and submitted to the same quaternarization process. All compounds were analyzed for their DNA binding properties by competition dialysis methods. In vitro antiproliferative tests were carried out against two different tumor cell lines. Docking experiments were conducted by including all four known human repeat unit G‐quadruplex DNA sequences (27 experimentally determined conformations) against the most active fluorenone derivatives. The results of theoretical, biophysical, and in vitro experiments indicate two novel derivatives as lead compounds for the development of a new generation of G‐quadruplex ligands with greater potency and selectivity. |
| |
Keywords: | docking fluorenones G‐quadruplex binders morpholine telomeres |
|
|